Cabot Co. (NYSE:CBT - Get Free Report) declared a quarterly dividend on Friday, November 8th,RTT News reports. Shareholders of record on Friday, November 29th will be given a dividend of 0.43 per share by the specialty chemicals company on Friday, December 13th. This represents a $1.72 dividend on an annualized basis and a yield of 1.50%.
Cabot has raised its dividend payment by an average of 3.9% annually over the last three years and has increased its dividend every year for the last 13 years. Cabot has a dividend payout ratio of 21.9% meaning its dividend is sufficiently covered by earnings. Equities research analysts expect Cabot to earn $8.72 per share next year, which means the company should continue to be able to cover its $1.72 annual dividend with an expected future payout ratio of 19.7%.
CBT stock traded down $1.61 during mid-day trading on Friday, reaching $114.99. 522,848 shares of the stock traded hands, compared to its average volume of 341,524. The company has a debt-to-equity ratio of 0.72, a quick ratio of 1.45 and a current ratio of 2.22. Cabot has a one year low of $70.63 and a one year high of $117.46. The stock has a market capitalization of $6.30 billion, a PE ratio of 17.30, a PEG ratio of 0.92 and a beta of 1.20. The business has a 50-day moving average price of $108.94 and a two-hundred day moving average price of $101.34.
Cabot (NYSE:CBT - Get Free Report) last posted its quarterly earnings data on Monday, November 4th. The specialty chemicals company reported $1.80 earnings per share for the quarter, missing analysts' consensus estimates of $1.81 by ($0.01). Cabot had a net margin of 9.51% and a return on equity of 27.14%. The firm had revenue of $1 billion for the quarter, compared to the consensus estimate of $1.01 billion. During the same quarter last year, the firm earned $1.65 EPS. The company's revenue was up 3.7% on a year-over-year basis. Equities research analysts expect that Cabot will post 7.82 EPS for the current year.
CBT has been the subject of a number of recent analyst reports. UBS Group lowered their target price on shares of Cabot from $103.00 to $98.00 and set a "neutral" rating for the company in a research note on Tuesday, August 6th. JPMorgan Chase & Co. boosted their target price on shares of Cabot from $95.00 to $105.00 and gave the company a "neutral" rating in a research note on Wednesday, August 7th. Finally, Mizuho upped their price objective on shares of Cabot from $103.00 to $122.00 and gave the stock an "outperform" rating in a research note on Tuesday. Three investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. According to MarketBeat, the company presently has an average rating of "Hold" and an average price target of $105.00.
Read Our Latest Stock Analysis on CBT
In other Cabot news, CEO Sean D. Keohane sold 25,617 shares of the stock in a transaction dated Tuesday, September 3rd. The shares were sold at an average price of $101.55, for a total transaction of $2,601,406.35. Following the completion of the sale, the chief executive officer now directly owns 331,174 shares of the company's stock, valued at approximately $33,630,719.70. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. In other Cabot news, CEO Sean D. Keohane sold 25,617 shares of the stock in a transaction dated Tuesday, September 3rd. The shares were sold at an average price of $101.55, for a total transaction of $2,601,406.35. Following the completion of the sale, the chief executive officer now directly owns 331,174 shares of the company's stock, valued at approximately $33,630,719.70. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, EVP Hobart Kalkstein sold 5,457 shares of the company's stock in a transaction dated Tuesday, August 20th. The shares were sold at an average price of $100.58, for a total transaction of $548,865.06. Following the transaction, the executive vice president now owns 61,688 shares in the company, valued at approximately $6,204,579.04. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 48,665 shares of company stock valued at $4,986,299. 3.07% of the stock is currently owned by insiders.
Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
Before you consider Cabot, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cabot wasn't on the list.
While Cabot currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.